Clinical Trials Details

S1207 (Breast)

A Phase III Randomized, Placebo- Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor Positive and HER2/NEU Negative Breast Cancer

Objective

This clinical trial was closed on May 1, 2019.

Clinical Trial Categories

  • Cancers and Other Neoplasms